1. Home
  2. EXPO vs AMRX Comparison

EXPO vs AMRX Comparison

Compare EXPO & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXPO
  • AMRX
  • Stock Information
  • Founded
  • EXPO 1967
  • AMRX 2002
  • Country
  • EXPO United States
  • AMRX United States
  • Employees
  • EXPO N/A
  • AMRX N/A
  • Industry
  • EXPO Professional Services
  • AMRX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EXPO Consumer Discretionary
  • AMRX Health Care
  • Exchange
  • EXPO Nasdaq
  • AMRX Nasdaq
  • Market Cap
  • EXPO 3.5B
  • AMRX 3.3B
  • IPO Year
  • EXPO 1990
  • AMRX N/A
  • Fundamental
  • Price
  • EXPO $66.93
  • AMRX $9.72
  • Analyst Decision
  • EXPO
  • AMRX Buy
  • Analyst Count
  • EXPO 0
  • AMRX 3
  • Target Price
  • EXPO N/A
  • AMRX $12.00
  • AVG Volume (30 Days)
  • EXPO 407.7K
  • AMRX 1.7M
  • Earning Date
  • EXPO 10-30-2025
  • AMRX 10-30-2025
  • Dividend Yield
  • EXPO 1.82%
  • AMRX N/A
  • EPS Growth
  • EXPO N/A
  • AMRX N/A
  • EPS
  • EXPO 1.99
  • AMRX 0.01
  • Revenue
  • EXPO $519,154,000.00
  • AMRX $2,852,914,000.00
  • Revenue This Year
  • EXPO $4.31
  • AMRX $9.52
  • Revenue Next Year
  • EXPO $7.48
  • AMRX $6.31
  • P/E Ratio
  • EXPO $33.09
  • AMRX $897.32
  • Revenue Growth
  • EXPO 2.10
  • AMRX 9.81
  • 52 Week Low
  • EXPO $63.81
  • AMRX $6.69
  • 52 Week High
  • EXPO $115.75
  • AMRX $10.68
  • Technical
  • Relative Strength Index (RSI)
  • EXPO 41.55
  • AMRX 44.69
  • Support Level
  • EXPO $64.39
  • AMRX $10.35
  • Resistance Level
  • EXPO $69.92
  • AMRX $10.61
  • Average True Range (ATR)
  • EXPO 1.15
  • AMRX 0.28
  • MACD
  • EXPO -0.17
  • AMRX -0.08
  • Stochastic Oscillator
  • EXPO 45.93
  • AMRX 19.49

About EXPO Exponent Inc.

Exponent Inc is a science and engineering consulting firm that provides solutions to complex problems. The company's consultant team is composed of scientists, physicians, engineers, as well as business and regulatory consultants. The company currently operates through two segments. The engineering and other scientific segments, which account for the majority of revenue, provide servicing encompassing biomechanics, biomedical engineering, buildings and structures, civil engineering, construction consulting, etc. The environmental and health segment covers chemical regulation and food safety, ecological and biological sciences, environmental and earth sciences and others. The company generates almost all of its revenues from America.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: